The Scientist

» books and disease/medicine

Most Recent

image: How Mole Rats Fight Cancer

How Mole Rats Fight Cancer

By | November 6, 2012

Blind mole rats resist cancer by killing cells that proliferate in a similar way to tumor cells.

0 Comments

image: The Brain on Anesthetics

The Brain on Anesthetics

By | November 5, 2012

Recording brain activity as patients are anesthetized for surgery, researchers identify a pattern that may signal loss of consciousness.  

1 Comment

image: Gingers More Prone to Skin Cancer

Gingers More Prone to Skin Cancer

By | November 2, 2012

Researchers identify an unexpected molecular explanation for the higher incidence of skin cancer in redheads.

5 Comments

image: Book Excerpt from The Science of Consequences

Book Excerpt from The Science of Consequences

By | November 1, 2012

In Chapter 2, "Consequences and Evolution: The Cause That Works Backwards," author Susan M. Schneider places evolutionary theory in terms of the science of consequences.

1 Comment

image: Capsule Reviews

Capsule Reviews

By | November 1, 2012

Spillover, Answers for Aristotle, Who’s in Charge? and Science Set Free

1 Comment

image: Contributors

Contributors

By | November 1, 2012

Meet some of the people featured in the November 2012 issue of The Scientist.

0 Comments

image: Omega-3s: Fishing for a Mechanism

Omega-3s: Fishing for a Mechanism

By | November 1, 2012

Despite abundant evidence supporting their ability to help prevent and treat cardiovascular disease, the therapeutic effectiveness of fish oil–derived fatty acids remains controversial.

4 Comments

image: The Road Less Traveled

The Road Less Traveled

By | November 1, 2012

First, Aravinda Chakravarti drew a map of how scientists might unravel the genetics of complex disease. Then he blazed the trail.

0 Comments

image: Truth and Consequences

Truth and Consequences

By | November 1, 2012

Studying the consequences of behavior has shed light on a wide range of life-science phenomena, pathological as well as everyday.

2 Comments

image: Tumor Snipers

Tumor Snipers

By | November 1, 2012

After two headline successes, companies rush to develop “smart bomb” cancer drugs.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech